Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
62°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
April 26, 2023
Tags
Eisai Co Ltd
Business
Biotech and Pharmaceuticals
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Breaking News: Business
Science
Companies
From
CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023
Tags
Pharmaceuticals
Biogen Inc
Health care industry
From
CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
April 06, 2023
Tags
Breaking News: Business
Science
Companies
From
CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
April 05, 2023
Tags
Breaking news
Companies
Science
From
CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
March 22, 2023
Tags
Biogen Inc
Health care industry
Pharmaceuticals
From
CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
March 20, 2023
Tags
Business
Biotech and Pharmaceuticals
US: News
From
CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
March 13, 2023
Tags
Coronavirus
Health & Science
US Top News and Analysis
From
CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
March 06, 2023
Tags
U/S/ Economy
Disease outbreaks
Biotechnology
From
CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
February 23, 2023
Tags
Disease outbreaks
Biotechnology
US: News
From
CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
February 17, 2023
Tags
Business
Moderna Inc
Finance
From
CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
February 17, 2023
Tags
Coronavirus
Health & Science
US Top News and Analysis
From
CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
February 17, 2023
Tags
U/S/ Economy
Business News
World News
From
CNBC.com News
Stocks making the biggest moves premarket: Kraft Heinz, Paramount, Airbnb, Tripadvisor and more
February 15, 2023
Tags
Paramount Global
Stock Picks
Biogen Inc
From
CNBC.com News
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
January 06, 2023
Tags
World News
US: News
Biotechnology
From
CNBC.com News
Stocks making the biggest moves midday: Mission Produce, Nutanix, Alphabet, Tesla and more
December 23, 2022
Tags
Halliburton Co
Norwegian Cruise Line Holdings Ltd
Economy
From
CNBC.com News
Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more
December 23, 2022
Tags
3M Co
Market Insider
Biogen Inc
From
CNBC.com News
Stocks making the biggest moves midday: CrowdStrike, Horizon Therapeutics, Petco and more
November 30, 2022
Tags
Stock markets
Breaking News: Markets
Finance
From
CNBC.com News
Stocks making the biggest moves premarket: Hormel, Petco, CrowdStrike and more
November 30, 2022
Tags
Economy
Workday Inc
NetApp Inc
From
CNBC.com News
Stocks making the biggest moves midday: Apple, DraftKings, Biogen, Williams-Sonoma and more
November 28, 2022
Tags
Business
Beyond Meat Inc
AB INBEV DRN
From
CNBC.com News
Stocks making the biggest moves in the premarket: Apple, Taboola, Biogen and more
November 28, 2022
Tags
MGM Resorts International
Earnings
Las Vegas Sands Corp
From
CNBC.com News
Stocks making the biggest moves midday: Oatly, Amazon, Hasbro and more
November 14, 2022
Tags
BlackRock Inc
Business
Wisdomtree Inc
From
CNBC.com News
Stocks making the biggest moves in the premarket: Hasbro, Oatly, Advanced Micro Devices and more
November 14, 2022
Tags
Amazon/com Inc
Oatly Group AB
Virgin Galactic Holdings Inc
From
CNBC.com News
Stocks making the biggest moves midday: Harley-Davidson, Visa, Microsoft, Biogen and more
October 26, 2022
Tags
Microsoft Corp
Dividends
Breaking news
From
CNBC.com News
Stocks making the biggest moves midday: Digital World, Domino's, Revlon, Albertsons and more
October 13, 2022
Tags
Albertsons Companies Inc
Earnings
Digital World Acquisition Corp
From
CNBC.com News
Jim Cramer goes over the best and worst Q3 performers in the S&P 500
October 11, 2022
Tags
FedEx Corp
Enphase Energy Inc
Lumen Technologies Inc
From
CNBC.com News
Stocks making the biggest moves midday: Apple, Netflix, Biogen, Canopy Growth and more
September 28, 2022
Tags
Paychex Inc
Breaking News: Markets
Newmont Corporation
From
CNBC.com News
Stocks making the biggest moves premarket: Biogen, Thor Industries, Lyft and more
September 28, 2022
Tags
BlackBerry
Thor Industries Inc
stocks
From
CNBC.com News
Biogen to pay $900 million to settle allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs
September 26, 2022
Tags
Biotech and Pharmaceuticals
Business
US Economy
From
CNBC.com News
Stocks making the biggest moves midday: Netflix, Las Vegas Sands, Bath & Body Works and more
July 20, 2022
Tags
Breaking news
Economy
Nasdaq Inc
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.